Head And Neck Cancer - Pipeline Review, H2 2016

Date: October 26, 2016
Pages: 1153
Price:
US$ 2,500.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H793E1D896CEN
Leaflet:

Download PDF Leaflet

Head And Neck Cancer - Pipeline Review, H2 2016
Head And Neck Cancer - Pipeline Review, H2 2016

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 17, 73, 86, 6, 76, 18 and 2 respectively for Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 9, 6, 16 and 3 molecules, respectively for Head And Neck Cancer.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Introduction
Head And Neck Cancer Overview
Therapeutics Development
Head And Neck Cancer - Therapeutics under Development by Companies
Head And Neck Cancer - Therapeutics under Investigation by Universities/Institutes
Head And Neck Cancer - Pipeline Products Glance
Head And Neck Cancer - Products under Development by Companies
Head And Neck Cancer - Products under Investigation by Universities/Institutes
Head And Neck Cancer - Companies Involved in Therapeutics Development
Head And Neck Cancer - Therapeutics Assessment
Drug Profiles
Head And Neck Cancer - Dormant Projects 1081
Head And Neck Cancer - Discontinued Products 1097
Head And Neck Cancer - Product Development Milestones 1100
Appendix 1119

LIST OF TABLES

Number of Products under Development for Head And Neck Cancer, H2 2016
Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H2 2016
Number of Products under Development by Companies, H2 2016
Number of Products under Development by Companies, H2 2016 (Contd..1)
Number of Products under Development by Companies, H2 2016 (Contd..2)
Number of Products under Development by Companies, H2 2016 (Contd..3)
Number of Products under Development by Companies, H2 2016 (Contd..4)
Number of Products under Development by Companies, H2 2016 (Contd..5)
Number of Products under Development by Companies, H2 2016 (Contd..6)
Number of Products under Development by Companies, H2 2016 (Contd..7)
Number of Products under Development by Companies, H2 2016 (Contd..8)
Number of Products under Development by Companies, H2 2016 (Contd..9)
Number of Products under Development by Companies, H2 2016 (Contd..10)
Number of Products under Development by Companies, H2 2016 (Contd..11)
Number of Products under Development by Companies, H2 2016 (Contd..12)
Number of Products under Development by Companies, H2 2016 (Contd..13)
Number of Products under Investigation by Universities/Institutes, H2 2016
Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1)
Comparative Analysis by Late Stage Development, H2 2016
Comparative Analysis by Clinical Stage Development, H2 2016
Comparative Analysis by Early Stage Development, H2 2016
Comparative Analysis by Unknown Stage Development, H2 2016
Products under Development by Companies, H2 2016
Products under Development by Companies, H2 2016 (Contd..1)
Products under Development by Companies, H2 2016 (Contd..2)
Products under Development by Companies, H2 2016 (Contd..3)
Products under Development by Companies, H2 2016 (Contd..4)
Products under Development by Companies, H2 2016 (Contd..5)
Products under Development by Companies, H2 2016 (Contd..6)
Products under Development by Companies, H2 2016 (Contd..7)
Products under Development by Companies, H2 2016 (Contd..8)
Products under Development by Companies, H2 2016 (Contd..9)
Products under Development by Companies, H2 2016 (Contd..10)
Products under Development by Companies, H2 2016 (Contd..11)
Products under Development by Companies, H2 2016 (Contd..12)
Products under Development by Companies, H2 2016 (Contd..13)
Products under Development by Companies, H2 2016 (Contd..14)
Products under Development by Companies, H2 2016 (Contd..15)
Products under Development by Companies, H2 2016 (Contd..16)
Products under Development by Companies, H2 2016 (Contd..17)
Products under Development by Companies, H2 2016 (Contd..18)
Products under Development by Companies, H2 2016 (Contd..19)
Products under Development by Companies, H2 2016 (Contd..20)
Products under Investigation by Universities/Institutes, H2 2016
Products under Investigation by Universities/Institutes, H2 2016 (Contd..1)
Products under Investigation by Universities/Institutes, H2 2016 (Contd..2)
Head And Neck Cancer - Pipeline by 3SBio Inc., H2 2016
Head And Neck Cancer - Pipeline by 4SC AG, H2 2016
Head And Neck Cancer - Pipeline by AB Science SA, H2 2016
Head And Neck Cancer - Pipeline by AbbVie Inc, H2 2016
Head And Neck Cancer - Pipeline by Accelerated Pharma, Inc., H2 2016
Head And Neck Cancer - Pipeline by Acceleron Pharma, Inc., H2 2016
Head And Neck Cancer - Pipeline by Adaptimmune Therapeutics Plc, H2 2016
Head And Neck Cancer - Pipeline by Aduro BioTech, Inc., H2 2016
Head And Neck Cancer - Pipeline by Advaxis, Inc., H2 2016
Head And Neck Cancer - Pipeline by Advenchen Laboratories, LLC, H2 2016
Head And Neck Cancer - Pipeline by Affimed GmbH , H2 2016
Head And Neck Cancer - Pipeline by Alchemia Limited, H2 2016
Head And Neck Cancer - Pipeline by Altor BioScience Corporation, H2 2016
Head And Neck Cancer - Pipeline by Ambrx, Inc., H2 2016
Head And Neck Cancer - Pipeline by Amgen Inc., H2 2016
Head And Neck Cancer - Pipeline by arGEN-X BV, H2 2016
Head And Neck Cancer - Pipeline by ArQule, Inc., H2 2016
Head And Neck Cancer - Pipeline by Aspyrian Therapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by Astellas Pharma Inc., H2 2016
Head And Neck Cancer - Pipeline by AstraZeneca Plc, H2 2016
Head And Neck Cancer - Pipeline by Atara Biotherapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by ATLAB Pharma SAS, H2 2016
Head And Neck Cancer - Pipeline by Aura Biosciences, Inc., H2 2016
Head And Neck Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H2 2016
Head And Neck Cancer - Pipeline by Bayer AG, H2 2016
Head And Neck Cancer - Pipeline by Betta Pharmaceuticals Co. Ltd., H2 2016
Head And Neck Cancer - Pipeline by Bexion Pharmaceuticals, LLC, H2 2016
Head And Neck Cancer - Pipeline by Bio-Path Holdings, Inc., H2 2016
Head And Neck Cancer - Pipeline by BioDiem Ltd, H2 2016
Head And Neck Cancer - Pipeline by Biomics Biotechnologies Co., Ltd., H2 2016
Head And Neck Cancer - Pipeline by Bionovis SA, H2 2016
Head And Neck Cancer - Pipeline by BioNTech AG, H2 2016
Head And Neck Cancer - Pipeline by Biotest AG, H2 2016
Head And Neck Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2016
Head And Neck Cancer - Pipeline by Boston Biomedical, Inc., H2 2016
Head And Neck Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2016
Head And Neck Cancer - Pipeline by Calithera Biosciences, Inc., H2 2016
Head And Neck Cancer - Pipeline by CEL-SCI Corporation, H2 2016
Head And Neck Cancer - Pipeline by Celgene Corporation, H2 2016
Head And Neck Cancer - Pipeline by Cell Medica Limited, H2 2016
Head And Neck Cancer - Pipeline by Cellceutix Corporation, H2 2016
Head And Neck Cancer - Pipeline by Celldex Therapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by Celprogen, Inc., H2 2016
Head And Neck Cancer - Pipeline by Centrose LLC, H2 2016
Head And Neck Cancer - Pipeline by Corvus Pharmaceuticals, Inc., H2 2016
Head And Neck Cancer - Pipeline by Cristal Therapeutics B.V., H2 2016
Head And Neck Cancer - Pipeline by Critical Outcome Technologies Inc., H2 2016
Head And Neck Cancer - Pipeline by CTI BioPharma Corp., H2 2016
Head And Neck Cancer - Pipeline by Daiichi Sankyo Company, Limited, H2 2016
Head And Neck Cancer - Pipeline by DNJ Pharma, Inc., H2 2016
Head And Neck Cancer - Pipeline by Eisai Co., Ltd., H2 2016
Head And Neck Cancer - Pipeline by Eleven Biotherapeutics Inc., H2 2016
Head And Neck Cancer - Pipeline by Eli Lilly and Company, H2 2016
Head And Neck Cancer - Pipeline by EntreChem, S.L., H2 2016
Head And Neck Cancer - Pipeline by Etubics Corporation, H2 2016
Head And Neck Cancer - Pipeline by Eureka Therapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016
Head And Neck Cancer - Pipeline by Five Prime Therapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by G&E Herbal Biotechnology Co., Ltd., H2 2016
Head And Neck Cancer - Pipeline by Genelux Corporation, H2 2016
Head And Neck Cancer - Pipeline by GeneSegues Inc, H2 2016
Head And Neck Cancer - Pipeline by Genexine, Inc., H2 2016
Head And Neck Cancer - Pipeline by Genmab A/S, H2 2016
Head And Neck Cancer - Pipeline by Genticel S.A., H2 2016
Head And Neck Cancer - Pipeline by GlaxoSmithKline Plc, H2 2016
Head And Neck Cancer - Pipeline by Gliknik, Inc., H2 2016
Head And Neck Cancer - Pipeline by Glycotope GmbH, H2 2016
Head And Neck Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2016
Head And Neck Cancer - Pipeline by Hookipa Biotech AG, H2 2016
Head And Neck Cancer - Pipeline by Horizon Pharma Plc, H2 2016
Head And Neck Cancer - Pipeline by Hutchison MediPharma Limited, H2 2016
Head And Neck Cancer - Pipeline by Ignyta, Inc., H2 2016
Head And Neck Cancer - Pipeline by Immunomedics, Inc., H2 2016
Head And Neck Cancer - Pipeline by Immunovaccine, Inc., H2 2016
Head And Neck Cancer - Pipeline by Immunovative Therapies, Ltd., H2 2016
Head And Neck Cancer - Pipeline by Incuron, LLC, H2 2016
Head And Neck Cancer - Pipeline by Incyte Corporation, H2 2016
Head And Neck Cancer - Pipeline by Infinity Pharmaceuticals, Inc., H2 2016
Head And Neck Cancer - Pipeline by Innate Pharma S.A., H2 2016
Head And Neck Cancer - Pipeline by Inovio Pharmaceuticals, Inc., H2 2016
Head And Neck Cancer - Pipeline by InteRNA Technologies B.V., H2 2016
Head And Neck Cancer - Pipeline by IRX Therapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by ISA Pharmaceuticals B.V., H2 2016
Head And Neck Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co., Ltd., H2 2016
Head And Neck Cancer - Pipeline by Johnson & Johnson, H2 2016
Head And Neck Cancer - Pipeline by Kite Pharma Inc, H2 2016
Head And Neck Cancer - Pipeline by Kolltan Pharmaceuticals, Inc., H2 2016
Head And Neck Cancer - Pipeline by Kura Oncology, Inc., H2 2016
Head And Neck Cancer - Pipeline by Laboratoires Pierre Fabre SA, H2 2016
Head And Neck Cancer - Pipeline by Lakewood-Amedex Inc, H2 2016
Head And Neck Cancer - Pipeline by Loxo Oncology, Inc., H2 2016
Head And Neck Cancer - Pipeline by Lytix Biopharma AS, H2 2016
Head And Neck Cancer - Pipeline by Mabion SA, H2 2016
Head And Neck Cancer - Pipeline by Mabtech Limited, H2 2016
Head And Neck Cancer - Pipeline by MacroGenics, Inc., H2 2016
Head And Neck Cancer - Pipeline by Marsala Biotech Inc., H2 2016
Head And Neck Cancer - Pipeline by Mateon Therapeutics Inc, H2 2016
Head And Neck Cancer - Pipeline by MaxiVAX SA, H2 2016
Head And Neck Cancer - Pipeline by Meabco A/S, H2 2016
Head And Neck Cancer - Pipeline by MedImmune, LLC, H2 2016
Head And Neck Cancer - Pipeline by Merck & Co., Inc., H2 2016
Head And Neck Cancer - Pipeline by Merck KGaA, H2 2016
Head And Neck Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2016
Head And Neck Cancer - Pipeline by Millennium Pharmaceuticals Inc, H2 2016
Head And Neck Cancer - Pipeline by Mirati Therapeutics Inc., H2 2016
Head And Neck Cancer - Pipeline by Molecular Partners AG, H2 2016
Head And Neck Cancer - Pipeline by Moleculin Biotech Inc, H2 2016
Head And Neck Cancer - Pipeline by Molplex Ltd., H2 2016
Head And Neck Cancer - Pipeline by NanoCarrier Co., Ltd., H2 2016
Head And Neck Cancer - Pipeline by Natco Pharma Limited, H2 2016
Head And Neck Cancer - Pipeline by Neonc Technologies Inc, H2 2016
Head And Neck Cancer - Pipeline by Northwest Biotherapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by Novartis AG, H2 2016
Head And Neck Cancer - Pipeline by Omnitura Therapeutics Inc., H2 2016
Head And Neck Cancer - Pipeline by Oncobiologics, Inc., H2 2016
Head And Neck Cancer - Pipeline by Oncolys BioPharma Inc, H2 2016
Head And Neck Cancer - Pipeline by Oncolytics Biotech Inc., H2 2016
Head And Neck Cancer - Pipeline by Onconova Therapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by OncoSec Medical Incorporated, H2 2016
Head And Neck Cancer - Pipeline by Ono Pharmaceutical Co., Ltd., H2 2016
Head And Neck Cancer - Pipeline by Oryx GmbH & Co. KG, H2 2016
Head And Neck Cancer - Pipeline by Panacea Biotec Limited, H2 2016
Head And Neck Cancer - Pipeline by PCI Biotech Holding ASA, H2 2016
Head And Neck Cancer - Pipeline by PDS Biotechnology Corporation, H2 2016
Head And Neck Cancer - Pipeline by Pfizer Inc., H2 2016
Head And Neck Cancer - Pipeline by Pharma Mar, S.A., H2 2016
Head And Neck Cancer - Pipeline by Pique Therapeutics, H2 2016
Head And Neck Cancer - Pipeline by PlantForm Corporation, H2 2016
Head And Neck Cancer - Pipeline by Plexxikon Inc., H2 2016
Head And Neck Cancer - Pipeline by PNP Therapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by Profectus BioSciences, Inc., H2 2016
Head And Neck Cancer - Pipeline by ProNAi Therapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by Provectus Biopharmaceuticals, Inc., H2 2016
Head And Neck Cancer - Pipeline by R-Pharm, H2 2016
Head And Neck Cancer - Pipeline by Redx Pharma Plc, H2 2016
Head And Neck Cancer - Pipeline by Reliance Life Sciences Pvt. Ltd., H2 2016
Head And Neck Cancer - Pipeline by Sanofi, H2 2016
Head And Neck Cancer - Pipeline by Sapvax, H2 2016
Head And Neck Cancer - Pipeline by Sareum Holdings Plc, H2 2016
Head And Neck Cancer - Pipeline by Selecta Biosciences, Inc., H2 2016
Head And Neck Cancer - Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2016
Head And Neck Cancer - Pipeline by Shenzen SiBiono GeneTech Co., Ltd., H2 2016
Head And Neck Cancer - Pipeline by Shionogi & Co., Ltd., H2 2016
Head And Neck Cancer - Pipeline by Silence Therapeutics Plc, H2 2016
Head And Neck Cancer - Pipeline by Sillajen Biotherapeutics, H2 2016
Head And Neck Cancer - Pipeline by Sinil Pharmaceutical Co., Ltd, H2 2016
Head And Neck Cancer - Pipeline by SuviCa Inc., H2 2016
Head And Neck Cancer - Pipeline by Symphogen A/S, H2 2016
Head And Neck Cancer - Pipeline by SynCore Biotechnology Co., Ltd., H2 2016
Head And Neck Cancer - Pipeline by Taiwan Liposome Company, Ltd., H2 2016
Head And Neck Cancer - Pipeline by Takara Bio Inc., H2 2016
Head And Neck Cancer - Pipeline by Takis S.r.l., H2 2016
Head And Neck Cancer - Pipeline by Tara Immuno-Oncology Therapeutics LLC, H2 2016
Head And Neck Cancer - Pipeline by Tessa Therapeutics Pte Ltd, H2 2016
Head And Neck Cancer - Pipeline by Theravectys SA, H2 2016
Head And Neck Cancer - Pipeline by Tolero Pharmaceuticals, Inc., H2 2016
Head And Neck Cancer - Pipeline by TyrNovo Ltd., H2 2016
Head And Neck Cancer - Pipeline by UbiVac, LLC, H2 2016
Head And Neck Cancer - Pipeline by Vaccibody AS, H2 2016
Head And Neck Cancer - Pipeline by VasGene Therapeutics, Inc., H2 2016
Head And Neck Cancer - Pipeline by Vault Pharma Inc., H2 2016
Head And Neck Cancer - Pipeline by Vaxeal Holding SA, H2 2016
Head And Neck Cancer - Pipeline by VentiRx Pharmaceuticals, Inc., H2 2016
Head And Neck Cancer - Pipeline by Virttu Biologics Limited, H2 2016
Head And Neck Cancer - Pipeline by VLPbio, H2 2016
Head And Neck Cancer - Pipeline by VM Discovery, Inc., H2 2016
Head And Neck Cancer - Pipeline by Vyriad Inc, H2 2016
Head And Neck Cancer - Pipeline by Yabao Pharmaceutical Group Co., Ltd., H2 2016
Assessment by Monotherapy Products, H2 2016
Assessment by Combination Products, H2 2016
Number of Products by Stage and Target, H2 2016
Number of Products by Stage and Mechanism of Action, H2 2016
Number of Products by Stage and Route of Administration, H2 2016
Number of Products by Stage and Molecule Type, H2 2016
Head And Neck Cancer - Dormant Projects, H2 2016 1114
Head And Neck Cancer - Dormant Projects (Contd..1), H2 2016 1115
Head And Neck Cancer - Dormant Projects (Contd..2), H2 2016 1116
Head And Neck Cancer - Dormant Projects (Contd..3), H2 2016 1117
Head And Neck Cancer - Dormant Projects (Contd..4), H2 2016 1118
Head And Neck Cancer - Dormant Projects (Contd..5), H2 2016 1119
Head And Neck Cancer - Dormant Projects (Contd..6), H2 2016 1120
Head And Neck Cancer - Dormant Projects (Contd..7), H2 2016 1121
Head And Neck Cancer - Dormant Projects (Contd..8), H2 2016 1122
Head And Neck Cancer - Dormant Projects (Contd..9), H2 2016 1123
Head And Neck Cancer - Dormant Projects (Contd..10), H2 2016 1124
Head And Neck Cancer - Dormant Projects (Contd..11), H2 2016 1125
Head And Neck Cancer - Dormant Projects (Contd..12), H2 2016 1126
Head And Neck Cancer - Dormant Projects (Contd..13), H2 2016 1127
Head And Neck Cancer - Dormant Projects (Contd..14), H2 2016 1128
Head And Neck Cancer - Dormant Projects (Contd..15), H2 2016 1129
Head And Neck Cancer - Discontinued Products, H2 2016 1130
Head And Neck Cancer - Discontinued Products (Contd..1), H2 2016 1131
Head And Neck Cancer - Discontinued Products (Contd..2), H2 2016 1132

LIST OF FIGURES

Number of Products under Development for Head And Neck Cancer, H2 2016
Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H2 2016
Number of Products under Development by Companies, H2 2016
Number of Products under Investigation by Universities/Institutes, H2 2016
Comparative Analysis by Late Stage Development, H2 2016
Comparative Analysis by Clinical Stage Development, H2 2016
Comparative Analysis by Early Stage Products, H2 2016
Assessment by Monotherapy Products, H2 2016
Assessment by Combination Products, H2 2016
Number of Products by Top 10 Targets, H2 2016
Number of Products by Stage and Top 10 Targets, H2 2016
Number of Products by Top 10 Mechanism of Actions, H2 2016
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016
Number of Products by Top 10 Routes of Administration, H2 2016
Number of Products by Stage and Top 10 Routes of Administration, H2 2016
Number of Products by Top 10 Molecule Types, H2 2016
Number of Products by Stage and Top 10 Molecule Types, H2 2016
Skip to top


Colorectal Cancer - Pipeline Review, H2 2015 US$ 2,125.00 Dec, 2015 · 1511 pages
Prostate Cancer - Pipeline Review, H2 2015 US$ 2,125.00 Dec, 2015 · 1596 pages

Ask Your Question

Head And Neck Cancer - Pipeline Review, H2 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: